Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent RCC
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Nivolumab (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 01 Mar 2018 Status changed from not yet recruiting to withdrawn prior to enrolment due to competing trials. Stopped before IRB approval.
- 17 Nov 2016 New trial record